Trial
NCT05049850
A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Hansa Biopharma AB
Collaborators
—
Condition
Kidney Transplantation in Highly Sensitized Patients
Intervention
Imlifidase
Why stopped
Company decision, not due to any safety reason
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-21